SEC Form 4 · accession 0001209191-18-048862
Cue Biopharma, Inc. · CUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kerri-Ann Millar
Officer — VP-Finance
Period of report
Aug 29, 2018
Accepted (ET)
Aug 29, 2018 · 6:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645460
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 29, 2018 | P | 1,000 | $8.48 | A | 1,000 | D |
Table II — derivative securities
No Table II lines on this filing.